VP of $AMGN Sells 1000 Shares in Insider Sale

Matthew C. Busch, the Vice President of $AMGN, recently executed a transaction involving the sale of 1,000 shares of the company’s stock, resulting in proceeds amounting to around $375,790. This notable trade, disclosed through a filing with the Securities and Exchange Commission, represented the divestment of approximately 22.6% of the particular class of shares he held. Post this sale, Busch retains ownership of 3,423 shares within this category of $AMGN stock.

In the realm of insider trading activity surrounding $AMGN, transactions have been conducted on the open market by insiders on five occasions in the previous half-year period. Notably, all five of these trades comprised sales rather than purchases. A spotlight on some recent trades within $AMGN showcases that Murdo Gordon, the Executive Vice President overseeing Global Commercial Operations, executed the sale of 6,879 shares, generating proceeds of approximately $2,317,071. Meanwhile, Nancy A. Grygiel, the Senior Vice President and Chief Commercial Officer, engaged in two sales of 3,139 shares, amassing an estimated $1,058,666. Additionally, Rachna Khosla, the Senior Vice President emphasizing Business Development, divested 890 shares, resulting in earnings of about $299,255.

Turning attention towards hedge fund activity associated with $AMGN, it’s worth noting that a total of 1,413 institutional investors augmented their positions within $AMGN stock, while 1,328 investors saw fit to decrease their holdings in the most recent quarter. Notable adjustments within institutional portfolios include UBS AM’s removal of 13,593,173 shares, equivalent to a 74.7% reduction, with an approximate value of $4,449,181,454. Capital World Investors adopted an opposing strategy, adding 4,302,237 shares, which corresponds to a 22.9% increase, valuing at an estimated $1,408,165,192.

In terms of revenue, $AMGN realized revenues amounting to $9.9 billion in the fourth quarter of 2025, reflecting an 8.58% year-over-year increase. This uptick in revenue demonstrates positive growth in the financial performance of the company within this particular timeframe.

Furthermore, members of Congress have engaged in eight trades involving $AMGN stock within the last six months. These transactions encompass a mix of purchases and sales. For instance, Representative David Taylor was involved in four trades, with one purchase worth a maximum of $15,000 in January and three sales amounting to up to $45,000 in January, December, and September. In a similar vein, Representative Marjorie Taylor Greene conducted two purchases totaling a maximum of $30,000 in October and September. Conversely, there have been no sales associated with Representative Greene’s transactions.

Wall Street analysts have proffered assessments of $AMGN in recent months, resulting in two firms issuing “buy” ratings and one firm assigning a “sell” rating to the stock. Among the recent analyst ratings, BMO Capital recommended an “Outperform” stance on December 3, 2025, while Piper Sandler favored an “Overweight” designation on November 14, 2025. Conversely, B of A Securities issued an “Underperform” rating on September 26, 2025.

Multiple analysts have put forth price targets for $AMGN, with a total of 14 analysts providing median price targets over the last six months. The median target price stands at $350.0, with analysts such as Emily Field from Barclays setting a target price of $350.0 on February 20, 2026. Similarly, Mohit Bansal from Wells Fargo set a target price of $375.0 on February 19, 2026. Other analysts, including David Amsellem from Piper Sandler and Vamil Divan from Guggenheim, have offered target prices ranging from $309.0 to $432.0.

Ultimately, the fluid landscape of stock trading, insider activity, institutional investment, revenue generation, and analyst evaluations all play a critical role in painting a comprehensive picture of the inner workings of $AMGN. It is vital for investors to stay informed and monitor these variables to make informed decisions about their investment strategies.